Search Results - "Irvine, Darrell"

Refine Results
  1. 1

    Controlling timing and location in vaccines by Irvine, Darrell J., Aung, Aereas, Silva, Murillo

    Published in Advanced drug delivery reviews (2020)
    “…Vaccines are one of the most powerful technologies supporting public health. The adaptive immune response induced by immunization arises following appropriate…”
    Get full text
    Journal Article
  2. 2

    Delivering safer immunotherapies for cancer by Milling, Lauren, Zhang, Yuan, Irvine, Darrell J.

    Published in Advanced drug delivery reviews (15-05-2017)
    “…Cancer immunotherapy is now a powerful clinical reality, with a steady progression of new drug approvals and a massive pipeline of additional treatments in…”
    Get full text
    Journal Article
  3. 3

    Enhancing cancer immunotherapy with nanomedicine by Irvine, Darrell J., Dane, Eric L.

    Published in Nature reviews. Immunology (01-05-2020)
    “…Therapeutic targeting of the immune system in cancer is now a clinical reality and marked successes have been achieved, most notably through the use of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants by Bhagchandani, Sachin, Johnson, Jeremiah A., Irvine, Darrell J.

    Published in Advanced drug delivery reviews (01-08-2021)
    “…[Display omitted] Imidazoquinoline derivatives (IMDs) and related compounds function as synthetic agonists of Toll-like receptors 7 and 8 (TLR7/8) and one is…”
    Get full text
    Journal Article
  6. 6

    Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity by Zhang, Yuan, Li, Na, Suh, Heikyung, Irvine, Darrell J.

    Published in Nature communications (02-01-2018)
    “…Immunostimulatory agents such as agonistic anti-CD137 and interleukin (IL)−2 generate effective anti-tumor immunity but also elicit serious toxicities,…”
    Get full text
    Journal Article
  7. 7

    Shaping humoral immunity to vaccines through antigen-displaying nanoparticles by Irvine, Darrell J, Read, Benjamin J

    Published in Current opinion in immunology (01-08-2020)
    “…Strategies to qualitatively and quantitatively enhance the humoral response to immunizations with protein and polysaccharide antigens are of broad interest for…”
    Get full text
    Journal Article
  8. 8

    Drug delivery: One nanoparticle, one kill by Irvine, Darrell J

    Published in Nature materials (01-05-2011)
    “…By wrapping a ligand-functionalized lipid membrane around a silica core, nanoparticles with a fluid surface are created. These combine unprecedented…”
    Get full text
    Journal Article
  9. 9

    Beyond antigens and adjuvants: formulating future vaccines by Moyer, Tyson J, Zmolek, Andrew C, Irvine, Darrell J

    Published in The Journal of clinical investigation (01-03-2016)
    “…The need to optimize vaccine potency while minimizing toxicity in healthy recipients has motivated studies of the formulation of vaccines to control how, when,…”
    Get full text
    Journal Article
  10. 10

    Modulating Antigen Availability in Lymphoid Organs to Shape the Humoral Immune Response to Vaccines by Aung, Aereas, Irvine, Darrell J

    Published in The Journal of immunology (1950) (15-01-2024)
    “…Primary immune responses following vaccination are initiated in draining lymph nodes, where naive T and B cells encounter Ag and undergo coordinated steps of…”
    Get full text
    Journal Article
  11. 11

    Engineering synthetic vaccines using cues from natural immunity by Irvine, Darrell J., Swartz, Melody A., Szeto, Gregory L.

    Published in Nature materials (01-11-2013)
    “…The clinical application of vaccines has expanded from infectious diseases to cancer, enhancing our vision of how the immune system can be used to prevent and…”
    Get full text
    Journal Article
  12. 12

    Roles for Innate Immunity in Combination Immunotherapies by Moynihan, Kelly D, Irvine, Darrell J

    Published in Cancer research (Chicago, Ill.) (01-10-2017)
    “…Immunity to infectious agents involves a coordinated response of innate and adaptive immune cells working in concert, with many feed-forward and regulatory…”
    Get full text
    Journal Article
  13. 13

    A mobile home for T cells by Lei, Kewen, Irvine, Darrell J.

    Published in Nature materials (01-06-2024)
    “…Lyophilized lymph nodes are a natural scaffold to deliver chimeric antigen receptor (CAR) T cells to tumour resection sites, where they serve as a natural T…”
    Get full text
    Journal Article
  14. 14

    Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors by Zheng, Yiran, Tang, Li, Mabardi, Llian, Kumari, Sudha, Irvine, Darrell J

    Published in ACS nano (28-03-2017)
    “…Adoptive cell therapy (ACT) has achieved striking efficacy in B-cell leukemias, but less success treating other cancers, in part due to the rapid loss of ACT…”
    Get full text
    Journal Article
  15. 15

    Bio-inspired, bioengineered and biomimetic drug delivery carriers by Mitragotri, Samir, Yoo, Jin-Wook, Irvine, Darrell J, Discher, Dennis E

    Published in Nature reviews. Drug discovery (01-07-2011)
    “…Key Points There are various challenges and limitations associated with the delivery of free drugs. These include poor solubility, poor stability, unwanted…”
    Get full text
    Journal Article
  16. 16

    Engineering Nano- and Microparticles to Tune Immunity by Moon, James J., Huang, Bonnie, Irvine, Darrell J.

    Published in Advanced materials (Weinheim) (24-07-2012)
    “…The immune system can be a cure or cause of disease, fulfilling a protective role in attacking cancer or pathogenic microbes but also causing tissue…”
    Get full text
    Journal Article
  17. 17

    Guiding Principles in the Design of Molecular Bioconjugates for Vaccine Applications by Liu, Haipeng, Irvine, Darrell J.

    Published in Bioconjugate chemistry (20-05-2015)
    “…Antigen- and adjuvant-based bioconjugates that can stimulate the immune system play an important role in vaccine applications. Bioconjugates have demonstrated…”
    Get full text
    Journal Article
  18. 18

    Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo by Kato, Yu, Abbott, Robert K., Freeman, Brian L., Haupt, Sonya, Groschel, Bettina, Silva, Murillo, Menis, Sergey, Irvine, Darrell J., Schief, William R., Crotty, Shane

    Published in Immunity (Cambridge, Mass.) (15-09-2020)
    “…How antigen valency affects B cells in vivo during immune responses is not well understood. Here, using HIV immunogens with defined valencies ranging from 1 to…”
    Get full text
    Journal Article
  19. 19

    Structure-based programming of lymph-node targeting in molecular vaccines by Liu, Haipeng, Moynihan, Kelly D., Zheng, Yiran, Szeto, Gregory L., Li, Adrienne V., Huang, Bonnie, Van Egeren, Debra S., Park, Clara, Irvine, Darrell J.

    Published in Nature (London) (27-03-2014)
    “…An amphiphile vaccine consisting of a peptide antigen or adjuvant cargo linked to a lipophilic tail is shown to have improved potency and safety in mice by…”
    Get full text
    Journal Article
  20. 20

    Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy by Fan, Yuchen, Kuai, Rui, Xu, Yao, Ochyl, Lukasz J, Irvine, Darrell J, Moon, James J

    Published in Nano letters (13-12-2017)
    “…Despite their potential, conventional whole-cell cancer vaccines prepared by freeze–thawing or irradiation have shown limited therapeutic efficacy in clinical…”
    Get full text
    Journal Article